JEPI vs ROCY: Which Is the Better Pick in 2026?

Overview

JEPI and ROCY are both JPMorgan covered-call ETFs that harvest options premiums on equity exposure to deliver monthly income. JEPI is the original and substantially larger fund, tracking the S&P 500 Index (SPX) with $44.3B in assets since 2020; ROCY is a newer entrant launched in March 2026 with $223M in assets, also targeting S&P 500 exposure. Both charge 0.35% in expenses and yield around 8.16–8.19%, but they differ meaningfully in portfolio construction and volatility profile.

How they differ

The first and largest difference is underlying index selection: JEPI targets SPX (the large-cap S&P 500 futures contract), while ROCY targets the S&P 500 Index itself. This distinction matters for options liquidity and contract specifications, though both expose investors to broad large-cap U.S. equities.

The second difference is volatility dampening and beta. JEPI carries a beta of 0.45, meaning it historically moved at less than half the pace of its benchmark—a sign that the covered-call overlay and JPMorgan's call-writing strategy have compressed downside swings. ROCY reports a beta of 0.0, which is unusual and likely reflects either insufficient return history to calculate a meaningful beta (the fund is only weeks old) or a data lag in reporting.

The third difference is scale and track record. JEPI's $44.3B AUM and five-year history provide a proven operational footprint, consistent options-writing discipline, and deep liquidity in the ETF itself. ROCY, with just $223M and an inception date of March 19, 2026, is brand new and carries execution risk: unknown management consistency under different market regimes, potential liquidity issues in the fund shares, and no historical performance to evaluate.

Who each is best for

JEPI: Fits investors seeking predictable monthly income from a core U.S. equity holding, with tolerance for capped upside in exchange for downside dampening and a proven five-year track record. Works for those who value established fund operations and ample trading liquidity.

ROCY: Fits investors willing to accept limited performance history in exchange for a structurally similar covered-call strategy with an even newer inception. Suits those who view it as an alternative entry point to the covered-call space or who have conviction in JPMorgan's execution but want to compare fund outcomes over time.

Key risks to know

• NAV erosion at sustained high distribution yields: Both funds' 8%+ distribution rates rely on options premiums layered atop equity returns. If underlying equity appreciation stalls or turns negative, distributions may incorporate significant return-of-capital, eroding NAV over time. This risk is present in any synthetic-income strategy.

• Capped upside and call assignment: Covered calls limit gains if the S&P 500 rallies sharply. If SPX or the S&P 500 moves well above the call strike, the fund's upside is truncated—income replaces growth that investors in unhedged equity indexes would capture.

• ROCY execution and liquidity risk: With only weeks of operational history, ROCY has not weathered a market cycle or demonstrated consistency in options-writing discipline across different volatility regimes. Low AUM ($223M) raises questions about fund viability and the cost of future share redemptions if the fund fails to gain traction.

• Beta reporting uncertainty for ROCY: A reported beta of 0.0 is atypical for an equity fund and suggests either insufficient data or a reporting artifact. Until ROCY accumulates meaningful return history, its true volatility relative to the S&P 500 remains unclear.

Bottom line

JEPI's substantial AUM, five-year track record, and proven options execution make it the more established choice for investors comfortable with covered-call compression of upside in exchange for downside dampening. ROCY replicates the strategy but at an early stage with minimal trading history and scale, creating execution and liquidity unknowns. Both charge the same fee and yield similar rates, so the trade-off centers on confidence in a proven fund versus willingness to accept novelty—and the data scarcity that comes with it.